Ubiquitin-like protein ISG15 (Interferon-Stimulated Gene of 15 kDa) in host defense against heart failure in a mouse model of virus-induced cardiomyopathy

Circulation

Volumn 130, Issue 18, 2014, Pages 1589-1600

  Rahnefeld, Anna ^a   Klingel, Karin ^b   Schuermann, Anett ^a   Diny, Nicola L ^c   Althof, Nadine ^a   Lindner, Anika ^a   Bleienheuft, Philipp ^a   Savvatis, Konstantinos ^a   Respondek, Dorota ^a   Opitz, Elisa ^a   Ketscher, Lars ^d   Sauter, Martina ^b   Seifert, Ulrike ^e   Tschöpe, Carsten ^a,f   Poller, Wolfgang ^a   Knobeloch, Klaus Peter ^d   Voigt, Antje ^a,f  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^c JOHNS HOPKINS UNIVERSITY   (United States)

^d UNIVERSITY OF FREIBURG   (Germany)

^e OTTO VON GUERICKE UNIVERSITY   (Germany)

^f DZHK GERMAN CENTRE FOR CARDIOVASCULAR RESEARCH   (Germany)

Author keywords

Animal; Cardiomyopathy; Dilated; Human; Immunology; Infection; Inflammation; Interferon type I; ISG15 protein; Models; Myocarditis; Viruses

Indexed keywords

COLLAGEN; INTERFERON STIMULATED GENE FACTOR 15; PROTEINASE; TRANSCRIPTION FACTOR; UBIQUITIN; UNCLASSIFIED DRUG; VIRUS RNA; CYSTEINE PROTEINASE; CYTOKINE; G1P2 PROTEIN, MOUSE; PICORNAIN 2A, PICORNAVIRUS; VIRUS PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARDIOMYOPATHY; COLLAGEN FIBER; CONJUGATION; CONTROLLED STUDY; DEATH; FEMALE; HEART FAILURE; HEART MUSCLE CELL; HOST CELL; HOST RESISTANCE; MALE; MOUSE; MYOCARDITIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN MODIFICATION; VIRUS INFECTION; VIRUS INFECTIVITY; VIRUS REPLICATION; ADULT; ANIMAL; BIOPSY; C57BL MOUSE; COMPLICATION; CONGESTIVE CARDIOMYOPATHY; COXSACKIE VIRUS INFECTION; DISEASE MODEL; ENTEROVIRUS B; GENETICS; HUMAN; IMMUNOLOGY; INNATE IMMUNITY; METABOLISM; MIDDLE AGED; NATURAL KILLER CELL; PHYSIOLOGY; T LYMPHOCYTE; VIROLOGY;

ADULT; ANIMALS; BIOPSY; CARDIOMYOPATHY, DILATED; COXSACKIEVIRUS INFECTIONS; CYSTEINE ENDOPEPTIDASES; CYTOKINES; DISEASE MODELS, ANIMAL; ENTEROVIRUS B, HUMAN; FEMALE; HEART FAILURE; HUMANS; IMMUNITY, INNATE; KILLER CELLS, NATURAL; MALE; MICE, INBRED C57BL; MIDDLE AGED; MYOCYTES, CARDIAC; T-LYMPHOCYTES; UBIQUITINS; VIRAL PROTEINS; VIRUS REPLICATION;

EID: 84922393475     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.114.009847     Document Type: Article

References (47)

1. Esfandiarei M, McManus BM. Molecular biology and pathogenesis of viral myocarditis. Annu Rev Pathol. 2008; 3: 127-155.
2. Cooper LT Jr. Myocarditis. N Engl J Med. 2009; 360: 1526-1538.
3. Kühl U, Pauschinger M, Noutsias M, Seeberg B, Bock T, Lassner D, Poller W, Kandolf R, Schultheiss HP. High prevalence of viral genomes and multiple viral infections in the myocardium of adults with ?idiopathic? left ventricular dysfunction. Circulation. 2005; 111: 887-893.
4. Kühl U, Pauschinger M, Seeberg B, Lassner D, Noutsias M, Poller W, Schultheiss HP. Viral persistence in the myocardium is associated with progressive cardiac dysfunction. Circulation. 2005; 112: 1965-1970.
5. Caforio AL, Pankuweit S, Arbustini E, Basso C, Gimeno-Blanes J, Felix SB, Fu M, Heliö T, Heymans S, Jahns R, Klingel K, Linhart A, Maisch B, McKenna W, Mogensen J, Pinto YM, Ristic A, Schultheiss HP, Seggewiss H, Tavazzi L, Thiene G, Yilmaz A, Charron P, Elliott PM; European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur Heart J. 2013; 34: 2636-2648, 2648a.
6. Wessely R, Klingel K, Knowlton KU, Kandolf R. Cardioselective infection with coxsackievirus B3 requires intact type I interferon signaling: implications for mortality and early viral replication. Circulation. 2001; 103: 756-761.
7. Kühl U, Pauschinger M, Schwimmbeck PL, Seeberg B, Lober C, Noutsias M, Poller W, Schultheiss HP. Interferon-beta treatment eliminates cardiotropic viruses and improves left ventricular function in patients with myocardial persistence of viral genomes and left ventricular dysfunction. Circulation. 2003; 107: 2793-2798.
8. Deonarain R, Cerullo D, Fuse K, Liu PP, Fish EN. Protective role for interferon-beta in coxsackievirus B3 infection. Circulation. 2004; 110: 3540-3543.
9. Riad A, Westermann D, Zietsch C, Savvatis K, Becher PM, Bereswill S, Heimesaat MM, Lettau O, Lassner D, Dörner A, Poller W, Busch M, Felix SB, Schultheiss HP, Tschöpe C. TRIF is a critical survival factor in viral cardiomyopathy. J Immunol. 2011; 186: 2561-2570.
10. Kühl U, Lassner D, von Schlippenbach J, Poller W, Schultheiss HP. Interferon-beta improves survival in enterovirus-associated cardiomyopathy. J Am Coll Cardiol. 2012; 60: 1295-1296.
11. Haas AL, Ahrens P, Bright PM, Ankel H. Interferon induces a 15-kilodalton protein exhibiting marked homology to ubiquitin. J Biol Chem. 1987; 262: 11315-11323.
12. Bogunovic D, Byun M, Durfee LA, Abhyankar A, Sanal O, Mansouri D, Salem S, Radovanovic I, Grant AV, Adimi P, Mansouri N, Okada S, Bryant VL, Kong XF, Kreins A, Velez MM, Boisson B, Khalilzadeh S, Ozcelik U, Darazam IA, Schoggins JW, Rice CM, Al-Muhsen S, Behr M, Vogt G, Puel A, Bustamante J, Gros P, Huibregtse JM, Abel L, Boisson-Dupuis S, Casanova JL. Mycobacterial disease and impaired IFN-γ immunity in humans with inherited ISG15 deficiency. Science. 2012; 337: 1684-1688.
13. Lenschow DJ, Lai C, Frias-Staheli N, Giannakopoulos NV, Lutz A, Wolff T, Osiak A, Levine B, Schmidt RE, Garc?a-Sastre A, Leib DA, Pekosz A, Knobeloch KP, Horak I, Virgin HW 4th. IFN-stimulated gene 15 functions as a critical antiviral molecule against influenza, herpes, and Sindbis viruses. Proc Natl Acad Sci U S A. 2007; 104: 1371-1376.
14. Okumura A, Pitha PM, Harty RN. ISG15 inhibits Ebola VP40 VLP budding in an L-domain-dependent manner by blocking Nedd4 ligase activity. Proc Natl Acad Sci U S A. 2008; 105: 3974-3979.
15. Werneke SW, Schilte C, Rohatgi A, Monte KJ, Michault A, Arenzana- Seisdedos F, Vanlandingham DL, Higgs S, Fontanet A, Albert ML, Lenschow DJ. ISG15 is critical in the control of Chikungunya virus infection independent of UbE1L mediated conjugation. PLoS Pathog. 2011; 7: e1002322.
16. Okumura A, Lu G, Pitha-Rowe I, Pitha PM. Innate antiviral response targets HIV-1 release by the induction of ubiquitin-like protein ISG15. Proc Natl Acad Sci U S A. 2006; 103: 1440-1445.
17. Zhao C, Collins MN, Hsiang TY, Krug RM. Interferon-induced ISG15 pathway: an ongoing virus-host battle. Trends Microbiol. 2013; 21: 181-186.
18. Yuan W, Krug RM. Influenza B virus NS1 protein inhibits conjugation of the interferon (IFN)-induced ubiquitin-like ISG15 protein. EMBO J. 2001; 20: 362-371.
19. Zhao C, Beaudenon SL, Kelley ML, Waddell MB, Yuan W, Schulman BA, Huibregtse JM, Krug RM. The UbcH8 ubiquitin E2 enzyme is also the E2 enzyme for ISG15, an IFN-alpha/beta-induced ubiquitin-like protein. Proc Natl Acad Sci U S A. 2004; 101: 7578-7582.
20. Ketscher L, Basters A, Prinz M, Knobeloch KP. mHERC6 is the essential ISG15 E3 ligase in the murine system. Biochem Biophys Res Commun. 2012; 417: 135-140.
21. Zou W, Zhang DE. The interferon-inducible ubiquitin-protein isopeptide ligase (E3) EFP also functions as an ISG15 E3 ligase. J Biol Chem. 2006; 281: 3989-3994.
22. Kandolf R, Hofschneider PH. Molecular cloning of the genome of a cardiotropic Coxsackie B3 virus: full-length reverse-transcribed recombinant cDNA generates infectious virus in mammalian cells. Proc Natl Acad Sci U S A. 1985; 82: 4818-4822.
23. Osiak A, Utermöhlen O, Niendorf S, Horak I, Knobeloch KP. ISG15, an interferon-stimulated ubiquitin-like protein, is not essential for STAT1 signaling and responses against vesicular stomatitis and lymphocytic choriomeningitis virus. Mol Cell Biol. 2005; 25: 6338-6345.
24. Kim KI, Yan M, Malakhova O, Luo JK, Shen MF, Zou W, de la Torre JC, Zhang DE. Ube1L and protein ISGylation are not essential for alpha/beta interferon signaling. Mol Cell Biol. 2006; 26: 472-479.
25. Ebstein F, Voigt A, Lange N, Warnatsch A, Schröter F, Prozorovski T, Kuckelkorn U, Aktas O, Seifert U, Kloetzel PM, Krüger E. Immunoproteasomes are important for proteostasis in immune responses. Cell. 2013; 152: 935-937.
26. Voigt A, Trimpert C, Bartel K, Egerer K, Kuckelkorn U, Feist E, Gericke C, Klingel K, Kandolf R, Felix SB, Baumann G, Kloetzel PM, Stangl K, Staudt A. Lack of evidence for a pathogenic role of proteasomedirected autoimmunity in dilated cardiomyopathy. Basic Res Cardiol. 2010; 105: 557-567.
27. Marienfeld U, Haack A, Thalheimer P, Schneider-Rasp S, Brackmann HH, Poller W. 'Autoreplication' of the vector genome in recombinant adenoviral vectors with different E1 region deletions and transgenes. Gene Ther. 1999; 6: 1101-1113.
28. Rahnefeld A, Ebstein F, Albrecht N, Opitz E, Kuckelkorn U, Stangl K, Rehm A, Kloetzel PM, Voigt A. Antigen-presentation capacity of dendritic cells is impaired in ongoing enterovirus myocarditis. Eur J Immunol. 2011; 41: 2774-2781.
29. Klingel K, Hohenadl C, Canu A, Albrecht M, Seemann M, Mall G, Kandolf R. Ongoing enterovirus-induced myocarditis is associated with persistent heart-muscle infection: quantitative-analysis of virus-replication, tissuedamage, and inflammation. Proc Natl Acad Sci U S A. 1992; 89: 314-318.
30. Durfee LA, Lyon N, Seo K, Huibregtse JM. The ISG15 conjugation system broadly targets newly synthesized proteins: implications for the antiviral function of ISG15. Mol Cell. 2010; 38: 722-732.
31. Gradi A, Svitkin YV, Imataka H, Sonenberg N. Proteolysis of human eukaryotic translation initiation factor eIF4GII, but not eIF4GI, coincides with the shutoff of host protein synthesis after poliovirus infection. Proc Natl Acad Sci U S A. 1998; 95: 11089-11094.
32. Esfandiarei M, Luo H, Yanagawa B, Suarez A, Dabiri D, Zhang J, McManus BM. Protein kinase B/Akt regulates coxsackievirus B3 replication through a mechanism which is not caspase dependent. J Virol. 2004; 78: 4289-4298.
33. Eisener-Dorman AF, Lawrence DA, Bolivar VJ. Cautionary insights on knockout mouse studies: the gene or not the gene? Brain Behav Immun. 2009; 23: 318-324.
34. Mann DL. The emerging role of innate immunity in the heart and vascular system: for whom the cell tolls. Circ Res. 2011; 108: 1133-1145.
35. Sadler AJ, Williams BR. Interferon-inducible antiviral effectors. Nat Rev Immunol. 2008; 8: 559-568.
36. Klingel K, Hohenadl C, Canu A, Albrecht M, Seemann M, Mall G, Kandolf R. Ongoing enterovirus-induced myocarditis is associated with persistent heart muscle infection: quantitative analysis of virus replication, tissue damage, and inflammation. Proc Natl Acad Sci U S A. 1992; 89: 314-318.
37. Guerra S, Cáceres A, Knobeloch KP, Horak I, Esteban M. Vaccinia virus E3 protein prevents the antiviral action of ISG15. PLoS Pathog. 2008; 4: e1000096.
38. Kräusslich HG, Nicklin MJ, Toyoda H, Etchison D, Wimmer E. Poliovirus proteinase 2A induces cleavage of eucaryotic initiation factor 4F polypeptide p220. J Virol. 1987; 61: 2711-2718.
39. Lamphear BJ, Yan R, Yang F, Waters D, Liebig HD, Klump H, Kuechler E, Skern T, Rhoads RE. Mapping the cleavage site in protein synthesis initiation factor eIF-4 gamma of the 2A proteases from human Coxsackievirus and rhinovirus. J Biol Chem. 1993; 268: 19200-19203.
40. Sonenberg N. Regulation of translation by poliovirus. Adv Virus Res. 1987; 33: 175-204.
41. Zhao C, Denison C, Huibregtse JM, Gygi S, Krug RM. Human ISG15 conjugation targets both IFN-induced and constitutively expressed proteins functioning in diverse cellular pathways. Proc Natl Acad Sci U S A. 2005; 102: 10200-10205.
42. Zaheer RS, Wiehler S, Hudy MH, Traves SL, Pelikan JB, Leigh R, Proud D. Human rhinovirus-induced ISG15 selectively modulates epithelial antiviral immunity. Mucosal Immunol. 2014; 7: 1127-1138.
43. Kindermann I, Kindermann M, Kandolf R, Klingel K, Bültmann B, Müller T, Lindinger A, Böhm M. Predictors of outcome in patients with suspected myocarditis. Circulation. 2008; 118: 639-648.
44. Opavsky MA, Penninger J, Aitken K, Wen WH, Dawood F, Mak T, Liu P. Susceptibility to myocarditis is dependent on the response of alphabeta T lymphocytes to coxsackieviral infection. Circ Res. 1999; 85: 551-558.
45. Jäkel S, Kuckelkorn U, Szalay G, Plötz M, Textoris-Taube K, Opitz E, Klingel K, Stevanovic S, Kandolf R, Kotsch K, Stangl K, Kloetzel PM, Voigt A. Differential interferon responses enhance viral epitope generation by myocardial immunoproteasomes in murine enterovirus myocarditis. Am J Pathol. 2009; 175: 510-518.
46. Wessely R, Klingel K, Santana LF, Dalton N, Hongo M, Jonathan Lederer W, Kandolf R, Knowlton KU. Transgenic expression of replicationrestricted enteroviral genomes in heart muscle induces defective excitation- contraction coupling and dilated cardiomyopathy. J Clin Invest. 1998; 102: 1444-1453.
47. Yajima T, Knowlton KU. Viral myocarditis: from the perspective of the virus. Circulation. 2009; 119: 2615-2624.